Activities of Marisa MATIAS related to 2021/0048(NLE)
Shadow reports (1)
REPORT on the proposal for a Council regulation establishing the Joint Undertakings under Horizon Europe
Amendments (136)
Amendment 204 #
Recital 3
(3) To deliver on priorities and impact, European partnerships should be developed through a broad involvement of all relevant stakeholders across Europe including industry, research organisations, bodies with a public service mission at local, regional, national or international level, and civil society organisations such as foundations that support and/or carry out research and innovation. They should also be one of the measures to strengthen cooperation between private and/or public sector partners at the international level including by joining up research and innovation programmes and cross-border investment in research and innovation bringing mutual benefits to people and businesses while ensuring that the Union can uphold its interestsdependence in strategic areas.
Amendment 206 #
Recital 7
(7) Where relevant, pPartnerships should consider Technical Screening Criteria as of Art. 3 and the “Do No Significant Harm” principle as of Art. 17 of the Regulation (EU) 2020/852 as an instrument to improve their projects readiness and access to green financing that will be crucial for market uptake and wider deployment of the innovative technologies and solutions they will deliver. Scientific evidence is at the core of the Technical Screening Criteria. Research and innovation, pursued by Partnerships, should play an important role to help economic operators reach or go beyond the standards and thresholds set up in the Regulation and to keep the Technical Screening Criteria up-to-date and consistent with the European Green Deal objectives.
Amendment 210 #
Recital 10
(10) The research and innovation activities undertaken by the joint undertakings should be funded from Horizon Europe. To achieve maximum impact, the joint undertakings should develop close synergies with other Union programmes and funding instruments, particularly with those supporting the deployment of innovative solutions, education and regional development, environmental sustainability in order to increase economic and social cohesion and reduce imbalances.
Amendment 219 #
Recital 15
(15) This Regulation is based on the principles and criteria set out in the Horizon Europe Regulation, including openness and transparency, a strong leverage effect and long-term commitments of all the involved parties. One of the objectives of this Regulation is to ensure the openness of the initiatives to a broad range of entities, including newcomers. The partnerships should be open to any entity that is willing and capable to work towards the common goal, and promote broad and active participation of stakeholders in their activities, membership and governance, and to ensure that the results would be for the benefit of all Europeans, notably through a broad dissemination of results and pre- deployment activities across the Union in geographically balanced manner.
Amendment 228 #
Recital 20
(20) The Horizon Europe Regulation requires the partners to show their long term commitment, including a minimum share of public and/or private investments. Consequently, it is necessary for the Union to identify in this Regulation founding members established in member states, countries associated to the Horizon Europe Programme or international organisations. However, where necessary, it should be possible to expand the membership base of joint undertakings after they are established with associated members selected following open, fair and transparent procedures, taking into account in particular the new technological developments or the association of additional countries to the Horizon Europe Programme. Legal entities interested in supporting the joint undertakings’ objectives in their specific areas of research, without becoming a member, should also be offered the possibility to become contributing partners of these joint undertakings.
Amendment 230 #
Recital 21
(21) The establishment of a joint undertaking ensures a mutually beneficial public-private partnership for the members involved, including by promoting certainty on major budget allocations for the relevant industries over a period of seven years. Becoming a founding member or associated member, or one of their constituent or affiliated entities, allows gaining influence, either directly or through the industry representatives, in the governing board of the joint undertaking. The governing board is the decision-making body of the joint undertaking that decides on the long-term strategic orientation of the partnership, as well as its annual priorities. Founding members and associated members and if applicable representing their constituent entities, should therefore be able to contribute to the joint undertaking's agenda and priority setting through the adoption and possible amendment of the Strategic Research and Innovation Agenda, as well as the adoption of the annual work programme, including the content of the calls for proposals, the applicable funding rate per call topic, and the related rules for submission, evaluation, selection, award and review procedures.
Amendment 244 #
Recital 25
(25) The governance of joint undertakings should ensure that their decision-making processes are fit to keep pace with fast-changing socio-economic and technological environment and global challenges. Joint undertakings should benefit from the expertise, advice and support from all relevant stakeholders, in order to effectively implement their tasks and ensure synergies at Union and national level. Therefore, joint undertakings should be empowered to set up advisory bodies with a view to providing them with expert advice and carrying out any other task of an advisory nature that is necessary for the achievement of the joint undertakings' objectives. In setting up the advisory bodies, joint undertakings should ensure a gender balanced representation of experts within the scope of the activities of the joint undertaking, including with respect to gender balance. The advice provided by these bodies should bring in scientific perspectives as well as those of national and regional authorities and of other stakeholders of joint undertakings.
Amendment 250 #
Recital 29
(29) The joint undertakings should operate in an open, fair and transparent way, providing all relevant information in a timely manner to their appropriate bodies as well as promoting their activities, including information and dissemination activities, to the wider public.
Amendment 252 #
Recital 29 a (new)
(29 a) new) Joint Undertakings should ensure that the public is sufficiently informed of the Joint Undertakings activities, can provide timelyinformation on their respective websites, including the publication of relevant corporate documentation, such as annual activities,progress and financial reports and minutes of board meetings
Amendment 266 #
Recital 39
(39) In the context of the European Commission’s priority of “A European Green Deal”13 supported by the revised Union Bioeconomy Strategy14 , the EU Biodiversity Strategy15 , the Clean Planet for All Communication16 , the Circular Economy Action Plan17 and the new Farm to Fork communication18 , the European bio-based sector, including SMEs, regions and primary producers should become climate neutral, more circular and more sustainable while remaining competitive on the global scale. A strong, resource efficient and competitive bio-based innovation ecosystem can decrease dependency on and accelerate the substitution of non-renewable fossil raw materials and mineral resources. It can develop renewable bio-based products, materials, processes and nutrients from waste and biomass through sustainability and circularity-driven innovation. Such ecosystem can also create value from local feedstock – including waste, residues and side-streams – to deliver jobs, economic and social growth and development throughout the Union not only in urban areas but alsospecially in rural and coastal territories where biomass is produced and that are often peripheral regions that rarely benefit from industrial, economic and social development. _________________ 13 https://ec.europa.eu/info/strategy/priorities- 2019-2024/european-green-deal_en 14 COM(2018)673 final 15 COM/2020/380 final 16https://eur-lex.europa.eu/legal- content/EN/TXT/PDF/?uri=CELEX:52018 DC0773&from=EN 17 COM(2020)98 final 18 COM(2020)381 final
Amendment 270 #
Recital 42
(42) The main objective of the Clean Aviation Joint Undertaking should be to contribute to reducing the ecological footprint of aviation by accelerating the development of climate neutral aviation technologies for their earliest possible deployment, therefore significantly contributing to the ambitious environment impact mitigation goals of the European Green Deal, that is to say a 55% emissions reduction by 2030 compared to 1990 levels, and climate neutrality by 2050 at the latest and by tackling global societal challenges, including the Sustainable Development Goals and commitments under Paris Agreement. This objective can only be achieved through accelerating and optimising the research and innovation processes in aeronautics and by improving the global competitiveness of the Union aviation industry. The Clean Aviation Joint Undertaking should also ensure that cleaner aviation remains safe, secure and efficient for the transportation of passengers and goods by air.
Amendment 282 #
Recital 48
(48) Interest in Hydrogen has evolved dramatically in the last five years with all member states having signed and ratified the Conference of the Parties (COP21) Paris Agreement. At the end of 2019, the Commission presented the European Green Deal, which aims to transform the Union into a fair and prosperous society, with a modern, energy and resource-efficient and competitivsustainable economy, where there are no net emissions of greenhouse gases in 2050 at latest. Priority areas include cleanrenewable hydrogen, fuel cells, other alternative fuels and energy storage. Hydrogen is prominent in the July 2020 “Communicaelectrolysers, productions on a hydrogen strategy for a climate-neutral Europe and an EU Strategy for Energy System Integration” as well as for the launch of the European Clean Hydrogen Alliance that brings all stakeholders together to identify technology needs, investment opportunities and regulatory barriers to build a clean hydrogen ecosystem in the Unionf additional renewable energy and energy storage.
Amendment 284 #
Recital 49
(49) Dedicated research and innovation activities related to hydrogen applications have been supported since 2008, mainly through the Fuel Cell and Hydrogen Joint Undertakings (FCH Joint Undertaking and FCH 2 Joint Undertaking) under FP7 and Horizon 2020 as well as by traditional collaborative projects, covering all stages/fields of the hydrogen value chain. The Clean Hydrogen Joint Undertaking should strengthen and integrate Union scientific capacity to accelerate the development and improvement of advanced clean hydrogen applications ready for market, across energy, transport, building and industrial end- uses. This will only be possible if combined with strengthening competitiveness of the Union clean hydrogen value chain, and notably SMErenewable hydrogen applications.
Amendment 288 #
Recital 50
(50) To achieve the scientific objectives of the CleanRenewable Hydrogen Joint Undertaking, all sectors and all users concerned by the hydrogen economy should be given the possibility to get involved in preparing and implementing its Strategic Research and Innovation Agenda. The public sector should also be involved, especially regional and national authorities, the latter being responsible for setting up climate policies and measures related to market mechanisms, to fill in the gaps between ready-to-market technology development and large-scale uptake.
Amendment 291 #
Recital 51
(51) Since hydrogen can be deployed as a fuel, energy carrier and for storing energy it is essential that the cleanrenewable hydrogen partnership establishes structured collaboration with many other Horizon Europe partnerships, notably for end-use. The cleanrenewable hydrogen partnership should interact in particular with the zero emission road and waterborne transport, Europe’s railway, clean aviation, processes for the planet and clean steel partnerships. For that purpose, a structure should be set up reporting to the Governing Board in order to ensure the co-operation and synergies between these partnerships in the domain of hydrogen. The cleanrenewable hydrogen initiative would be the only partnership focused on addressing renewable hydrogen production technologies. Collaboration with end-use partnerships should in particular focus on demonstrating the technology and co- defining specifications.
Amendment 292 #
Recital 53
(53) The European Green Deal aims to transform the Union into a fair and prosperous society, with a modern, energy and resource-efficient and competitivsustainable economy where there are no net emissions of greenhouse gases by 2050 and where economic growth is decoupled from resource use. Priority areas include accelerating the shift to sustainable and smart mobility with the aim to deliver 90% reduction in the transport sectors emissions by 2050.
Amendment 296 #
Recital 54
(54) The Commission Communication on a New Industrial Strategy for Europe22 (March 2020) underlines that sustainable and smart mobility industries, such as the rail industry, have both the responsibility and the potential to drive the digital and green transition, support Europe’s industrial competitivenessindependence and improve connectivity. Therefore road, rail, aviation, and waterborne transport should all contribute to a 90% reduction in transport emissions by 2050. As a matter of priority, a substantial part of the 75% of inland freight carried today by road should shift onto rail and inland waterways. _________________ 22https://eur-lex.europa.eu/legal- content/EN/TXT/?qid=1593086905382&ur i=CELEX:52020DC0102
Amendment 302 #
Recital 61
(61) In the context of the Commission’s priorities of the United Nations Sustainable Development Goals, in particular SDG 3, and the Communication Towards a Comprehensive Strategy with Africa23 , the Union is committed to contribute to ensure healthy lives and promote well-being for all, to build an even stronger partnership between our two continents and to support the development of research and innovation capacities within Africa. The Global Health EDCTP3 Joint Undertaking should address the lack of appropriate diagnostics, treatments and vaccines, among other so-called health technologies, to address infectious diseases, such as HIV, malaria and tuberculosis, but also other poverty related and neglected infectious diseases, that are prevalent in Africa, especially in sub-Saharan Africa. The COVID19 pandemic has revealed that with the increased connectivity of different regions in the world, through world trade and tourism, infectious diseases can rapidly spread all over the world. Developing health technologies is therefore crucial to limit the spread of infectious diseases, as well as to fight them once they have spread, to protect the health of the citizens, to improve and foster health in the countries concerned and in the Union, by supporting health promotion and disease prevention, reducing health inequalities and ensuring equal and full access to health.. In order to achieve a stronger global health leadership than the current EDCTP2 initiative, the scope of the partnership should be extended to cover response to emerging infectious diseases threats, the increasing problems of antimicrobial resistance and non- communicable diseases co-morbidities. _________________ 23Joint Communication to the European Parliament and the Council: Towards a comprehensive Strategy with Africa, Brussels, 9.3.2020, JOIN(2020) 4 final.
Amendment 307 #
Recital 66
(66) In the context of the European Commission’s priorities of “An economy that works for people” and “A Europe fit for the digital age”, the European industry, including SMEs, should become greener, more circular and more digital while remaining competitive on the global scale and more social. The Commission has emphasized the role of medical devices and digital technologies addressing emerging challenges and the use of e-health services to provide high- quality health care, along with a call for ensuring the supply of affordable medicines to meet the Union’s needs, whilst supporting an innovative and world- leading European pharmaceutical industry. The Innovative Health Initiative Joint Undertaking aims to contribute towards strengthening the competitiveness of the Union’s health industry, a cornerstone of the Union’s knowledge-based economy, to an increased economic activity in the development of health technologies, notably of integrated health solutions, and thus serve as a tool for increasing technological sovereignty and fostering the digital transformation of our societies. Such political priorities can be achieved by bringing together the crucial players: the academia, companies of various sizes and end-users of health innovations, under the umbrella of a public-private partnership in health research and innovation. The Innovative Health Initiative Joint Undertaking should help reach the objectives of the ‘Europe’s Beating Cancer Plan’24 and the ‘European One Health Action Plan against Antimicrobial Resistance’25 . The Innovative Health Initiative Joint Undertaking should be aligned with the new Industrial Strategy for Europe26 , the Pharmaceutical Strategy for Europe27 and the SME strategy for a sustainable and digital Europe28 . _________________ 24 https://ec.europa.eu/info/law/better- regulation/have-your-say/initiatives/12154- Europe-s-Beating-Cancer-Plan 25 https://ec.europa.eu/health/sites/health/files /antimicrobial_resistance/docs/amr_2017_a ction-plan.pdf 26 COM(2020) 102. 27 COM(2020) 761. 28 COM(2020) 103.
Amendment 313 #
Recital 67
(67) The Innovative Health Initiative Joint Undertaking builds on the experience gained from the Innovative Medicine Initiative 2 Joint Undertaking (IMI2 Joint Undertaking) including the work done by this initiative to combat the COVID-19 pandemic. In line with the recommendations of the interim evaluation of IMI2 Joint Undertaking29 , a successor initiative needs to “enable the active engagement of other industry sectors with the pharmaceutical industry to capitalise on their expertise in the development of new health care interventions”. Therefore, the industry sectors need to cover the biopharmaceutical, biotechnology and medical technology sectors, including companies active in the digital area. The scope of the initiative should cover prevention, diagnosis, treatment and disease management and must be established taking due account of the high burden for patients and/or society due to the severity of the disease and/or the number of people affected, as well as the high economic impact of the disease for patients and for health care services and systems. The funded actions must respond to the Union public health needs, supporting the development of future health innovations that are safe, people- centred, effective, cost-effective and affordable for patients and for health care systemservices in order to improve the health of the population and health equality. _________________ 29The Interim Evaluation of the Innovative Medicines Initiative 2 Joint Undertaking (2014-2016) operating under Horizon 2020 (ISBN 978-92-79-69299-4).
Amendment 322 #
Recital 72
(72) The Key Digital Technologies Joint Undertaking should address clearly defined topics that would enable European industries at large to design, manufacture and use the most innovative technologies in electronic components and systems. Structured and coordinated financial support at European level is necessary to help research teams and European industries maintain their current strengths at the leading edge in a highly competitive international context and close the gap in technologies that are critical for a digital transformation in Europe that reflects core Union values including privacy and trust, security, data protection, trust, and safety. Collaboration among stakeholders of the ecosystem, representing all segments of the value chains, is essential for the development of new technologies and the fast market uptake of innovation. Openness, transparency and flexibility to integrate relevant stakeholders, including in particular SMEs, in emerging or adjacent areas of technology, or in both, is also vital.
Amendment 333 #
Recital 81
(81) The Single European Sky ATM Research 3 Joint Undertaking should build on the experience of the SESAR Joint Undertaking and continue its coordination role for ATM research in the Union. The main objectives of the Single European Sky ATM Research 3 Joint Undertaking should be to strengthen and further integrate the research and innovation capacity in Europe, helping to accelerate the digitalisation of the sector and rendering it more resilient and scalable to fluctuations in traffic. It should strengthen, through innovation, the competitiveness of manned and unmanned air transport and ATM services, to support economic recovery and growthsocial growth, in environmentally friendly manner. It should develop and accelerate the market uptake of innovative solutions to establish the Single European Sky airspace as the most efficient and environmentally friendly sky to fly in the world.
Amendment 338 #
Recital 89
(89) The Smart Networks and Services Joint Undertaking is designed to address policy issues in the field of digital infrastructure and to extend the technology scope of research and innovation for 6G networks. It should, with close involvement of member states, strengthen the response to Union policy and social needs regarding network energy efficiency, cybersecurity, technological sovereignty, privacy and ethics and will extend the research and innovation scope from networks to cloud based service provisioning as well as components and devices enabling services for citizens and a broad range of economic and social sectors such as health care, transport, manufacturing and media.
Amendment 350 #
Article 3 – paragraph 1 – point c
(c) the CleanRenewable Hydrogen Joint Undertaking;
Amendment 351 #
Article 4 – paragraph 1
1. The joint undertakings referred to in Article 3 shall contribute to the general objectives of the Horizon Europe Regulation as set out in [Article 3] thereofIn the implementation of the Horizon Europe Regulation, the joint undertakings shall respect the principles of open science set out in[Articles 10, 35] of that Regulation, requiring beneficiaries to provide open access to research results and data following the principle “as open as possible, as closed as necessary”. The joint undertakings shall lay out strict rules for derogations from these open access requirements. Costs related to open access including data management plans shall be eligible for reimbursement as further stipulated in the grant agreement.
Amendment 354 #
Article 4 – paragraph 2 – introductory part
2. The joint undertakings shall, through the involvement and commitment of partners in designing and implementing a programme of research and innovation activities, deliver on the following general objectives:
Amendment 359 #
Article 4 – paragraph 2 – point a
(a) strengthening and integrating the Union’s scientific and technological capacities to support the creation and diffusion of high-quality new knowledge notably with a view to deliver on global societal challenges, securing Union competitivenessresilience, sustainability and contributing to the a reinforced European Research Area;
Amendment 363 #
Article 4 – paragraph 2 – point b
(b) securupporting sustainability-driven global leadership of Union value chains and Union open strategic autonomy in key technologies and industries in line with the industrial strategy for Europe;European Green Deal.
Amendment 365 #
Article 4 – paragraph 2 – point c
(c) develop and accelerate the uptake of innovative solutions throughout the Union addressing climate, environmental, health, digital and other global societal challenges contributing to Union strategic priorities, in particular to reach the United Nations Sustainable Development Goals and achieve climate neutrality in the Union by 2050 at latest.
Amendment 372 #
Article 4 – paragraph 3 – point b
(b) accelerate the social, ecological and economic transitions in areas and sectors of strategic importance for Union priorities, in particular to reduce greenhouse gas emissions by 2030 in accordance with the climate and energy targets set in line with the European Green Deal;
Amendment 380 #
Article 4 – paragraph 3 – point e
(e) deliver environmental, sustainability, circularity and productivity improvements in new products and services thanks to a harnessing of Union capabilities and resources.
Amendment 388 #
Article 5 – paragraph 1 – point c
(c) reinforce the link between research, innovation, and where appropriate, education and other policieseducation, including complementarities with national and regional and Union research and innovation policies and activities and the Sustainable Goals and Paris Agreement;
Amendment 389 #
Article 5 – paragraph 1 – point c – indent 1 (new)
- strengthening the gender dimension across the joint undertakings;
Amendment 394 #
Article 5 – paragraph 1 – point f
(f) increase public awareness, acceptance, demand and uptake of new solutions by involving citizens and end- users in co-design and co-creation processes;
Amendment 395 #
Article 5 – paragraph 1 – point g
(g) encourage exploitthe development and application of research and innovation results and their actively disseminate and exploit results, in particular for leveraging private investments and policy development;ion.
Amendment 405 #
Article 5 – paragraph 2 – point a
(a) provide financial support, mainly in the form of grants, to research and innovation indirect actions, selected following open and competitive, fair and transparent calls, unless otherwise specified in their work programme;
Amendment 420 #
Article 5 – paragraph 2 – point i
(i) liaise with the most extensive range of stakeholders including, but not limited to, decentralised agencies, research organisations and universities, civil society organisations,end users and public authorities, in particular for the purpose of defining the priorities and activities of each initiative as well as to ensure inclusiveness;
Amendment 425 #
Article 5 – paragraph 2 – point n
Amendment 429 #
Article 5 – paragraph 2 – point o
(o) considerApply the ‘Do No Significant Harm Principle’ pursuant to Article 17 of Regulation (EU) 2020/852 and take into account the provisions of that Regulation to improve access to sustainable finance, where relevant;
Amendment 432 #
Article 7 – paragraph 1
Amendment 445 #
Article 9 – paragraph 1
1. Any candidate contributing partner as defined in Article 2(7) shall submit a letter of endorsement to the governing board. The letter of endorsement shall specify the scope of the partnership in terms of subject matter, activities and duration and detail the applicant’s contribution to the joint undertaking and shall be made public.
Amendment 448 #
Article 9 – paragraph 2
2. The governing board shall assess the letter of endorsement and shall approve or reject the application taking into account the advice of scientific advisory body.
Amendment 469 #
Article 11 – paragraph 9 – indent 1 (new)
- 10. The European Parliament shall be informed about any changes to the Union financial contributions.
Amendment 480 #
Article 14 – paragraph 2 – indent 1 (new)
- 3. The Governing Board shall ensure geographical and gender balance in its composition.
Amendment 487 #
Article 15 – paragraph 4
4. The governing board shall hold ordinary meetings at least twice a year. Extraordinary meetings may be convened at the request of the chairperson, of the executive director, of the Commission or of a majority of the representatives of the members other than the Union or of the participating states. The meetings of the governing board shall be convened by the chairperson and shall take place at the seat of the joint undertaking concerned, unless exceptionally decided otherwise by the governing board in duly justified cases. The meeting minutes shall be made public in a timely manner on the respective website of each partnership.
Amendment 499 #
Article 16 – paragraph 2 – point c
(c) assess, accept or reject applications of prospective contributing partners in accordance with Article 9 taking into account the advice of scientific advisory body in accordance with Article 19;
Amendment 514 #
Article 16 – paragraph 2 – point u
(u) adopt rules on the secondment of national experts, including their remuneration to the joint undertakings or the use of trainees;
Amendment 527 #
Article 17 – paragraph 1
1. The executive director shall be appointed by the governing board on the basis of merit and skills and impartiality, from the list of candidates proposed by the Commission, following an open and transparent selection procedure which shall respect the principle of gender balance.
Amendment 530 #
Article 17 – paragraph 2
2. The Commission shall propose a list of candidates for executive director after consultation with the members other than the Union of the joint undertaking. For the purpose of such consultation the members other than the Union of the joint undertaking shall appoint by common accord their representatives as well as an observer on behalf of the governing board. The list of the candidates for each Joint Undertaking shall be made public. Before appointment, the candidate selected by Governing Board shall make a statement before the competent committee of the European Parliament and answer questions put by its members.
Amendment 546 #
Article 18 – paragraph 6 – point b
(b) manage the implementation of the work programme of the joint undertaking throughout the implementation cycle and ensure that work programme and any changes to it are made public;
Amendment 551 #
Article 19 – paragraph 1 – subparagraph 1
Amendment 566 #
Article 19 – paragraph 7 – point f a (new)
(f a) assess and advice the governing boards on applications of potencial contributing partners;
Amendment 567 #
Article 19 – paragraph 7 – point g – indent 1 (new)
- (h) The governing boards shall inform without undue delay the advisory body of the follow up it has given to its advices, or it shall give reasons if they are not followed up.
Amendment 570 #
Article 19 – paragraph 8
8. After each meeting of the scientific advisory body, its chairperson shall submit to the governing board a report outlining the body’s and its members’ opinions on the matters discussed during the meeting. This report shall be also made public.
Amendment 574 #
Article 20 – paragraph 5
5. The chairperson of the states’ representatives group may invite other persons to attend its meetings as observers, in particular representatives of relevant federal or regional authorities within the Union, representatives of SME associations, civil society organisations and representatives of other bodies of the joint undertaking.
Amendment 585 #
Article 21 – paragraph 2
2. The stakeholders group shall be open to all public and private stakeholders, including organised groups, European social partners and civil society organisations, active in the field of the joint undertaking, international interest groups from member states, associated countries as well as from other countries.
Amendment 597 #
Article 24 – paragraph 1
1. The executive director shall provide the governing board with a consolidated annual activity report on the performance of his or her duties in accordance with the financial rules of the joint undertaking. The annual activities report shall be made public in a timely manner on the website of the respective partnership.
Amendment 622 #
Article 44 – paragraph 1 – point a
(a) accelerate the research and innovation process and development of sustainable bio-based innovative solutions;
Amendment 623 #
Article 44 – paragraph 1 – point b
(b) accelerate market deployment of the existing mature and innovative bio- based solutions that take into account the need to protect unique biodiversity and ecosystems;
Amendment 626 #
Article 44 – paragraph 1 – point c
(c) ensure a high level of environmental performance of bio-based industrial systems. that are sustainable and respect ecological limits;
Amendment 629 #
Article 44 – paragraph 2 – point b
(b) increase and integrate the research and innovation capacity of stakeholders across the Union to exploit the local bioeconomy potential while respecting the local ecosystems and biodiversity;
Amendment 632 #
Article 44 – paragraph 2 – point d
(d) reinforce the integration of bio- based research and innovation processes in Union industrial value chains in order to promote higher level of sustainability and circularity;
Amendment 634 #
Article 44 – paragraph 2 – point e
(e) reduce the risk for research and innovation investment in bio-based companies and sustainable bio-based projects;
Amendment 635 #
Article 44 – paragraph 2 – point f
(f) ensure that environmental considerations are taken into account in the development and implementation of research and innovation bio-based projects contribute to reaching Union's GHG emission reduction target and biodiversity objectives.
Amendment 639 #
Article 45 – paragraph 1 – point e
(e) mobilise and integrate research and innovation actors from rural, coastal, urban areas and regions, at various geographic levels with unexploited potential for bio- based industry development to co-operate in project activities;
Amendment 643 #
Article 45 – paragraph 1 – point g
(g) promote communication and collaboration between research and innovation actors and industrial stakeholders including small farmers under the Circular Bio-Based Europe Joint Undertaking to raise awareness about rapidly evolving knowledge and technology, facilitate cross- sector collaboration and facilitate market uptake of sustainable innovative bio-based solutions;
Amendment 645 #
Article 45 – paragraph 1 – point h
(h) mobilise national and regional authorities that are able to create more favourable conditions for market uptake of sustainable bio-based innovations;
Amendment 648 #
Article 45 – paragraph 1 – point j
(j) communicate and promote sustainable innovative bio-based solutions towards policy makers, industry, NGOs and consumers at large.
Amendment 673 #
Article 54 – paragraph 1
1. One or more Deployment Groups shall be established pursuant to Article 21. The role of the Deployment Groups is to advice the Governing Board on issues critical to market uptake of sustainable bio-based innovation and to promote deployment of sustainable bio-based solutions.
Amendment 676 #
Article 54 – paragraph 2
2. The composition of the Deployment Groups shall ensure appropriate thematic focus and representativeness of the bio-based innovation stakeholders and civil society organisations such as consumers organisation. Any stakeholder other than the members of the Bio-Based Industry Consortium, their constituents or their affiliated entities may express its interest to become members of a Deployment Group. The Governing Board shall set out the envisaged size and composition of the Deployment Groups, the duration of the mandates and the possibility of renewal of its members, and select their members. The list of members shall be publicly available.
Amendment 678 #
Article 54 – paragraph 3
3. The Deployment Groups shall meet at least once per year in a physical or virtual meeting. At the first meeting, the Deployment Groups shall adopt their rules of procedure. These rules of procedure shall be approved by the Governing Board. Extraordinary meetings of the Deployment Groups shall be called upon the request from the Governing Board. The Governing Board may request the participation of additional persons in the extraordinary meetings. The list of attendees to those extraordinary meetings shall be publicly available.
Amendment 680 #
Article 54 – paragraph 4
4. The Deployment Groups shall elect a chairperson, and a vice-chair per thematic focus, for a period of two years. The chairperson coordinates activities and represents the Deployment Group. The chairperson may be invited to meetings of the Governing Board as an observer without voting rights, and meetings of the Scientific Committee and the States Representatives Group.
Amendment 682 #
Article 54 – paragraph 5
5. The Deployment Groups shall provide recommendations on the issues related to the deployment of sustainable bio-based innovation upon request from the Governing Board. The Deployment Groups can also issue recommendations to the Governing Board anytime at their own initiative.
Amendment 683 #
Article 55 – paragraph 1 – point a
(a) to contribute to reduce the ecological footprint of aviation by accelerating the development of climate neutral aviation technologies for earliest possible deployment, therefore significantly contributing to the achievement of the general goals of the European Green Deal47 , in particular in relation to the reduction of Union-wide net greenhouse gas emissions reduction target of at least 55% by 2030, compared to 1990 levels and a pathway towards reaching climate neutrality by 2050 at latest; _________________ 47 Communication from the Commission to the European Parliament, the European Council, the Council, the European Economic and Social Committee and the Committee of the Regions, COM/2019/640 final.
Amendment 684 #
Article 55 – paragraph 1 – point b
(b) to ensure that aeronautics-related research and innovation activities contribute to the global sustainable competitiveness of the Union aviation industry, and to ensure that climate-neutral aviation technologies meet the relevant aviation safety requirements,48 and remains a secure, reliable, cost-effective,sustainable, affordable and efficient means of passenger and freight transportation; _________________ 48Regulation (EU) 2018/1139 of the European Parliament and of the Council of 4 July 2018 on common rules in the field of civil aviation and establishing a European Union Aviation Safety Agency.
Amendment 690 #
Article 55 – paragraph 2 – point c
(c) to expand and foster integration of the climate-neutral aviation research and innovations value chains, including academia, research organisations, industry, and SMEs,SMEs and trade unions also by benefitting from exploiting synergies with other national and European related programmes.
Amendment 691 #
Article 55 – paragraph 2 – point c – indent 1 (new)
- (d) to promote employment in the aviation sector that is specially important for the economic and social recovery by combining an emphasis on restoring growth and creating quality jobs with achievement of environmental goals.
Amendment 724 #
Part 2 – title III
Amendment 726 #
Article 71 – title
Additional objectives of the CleanRenewable Hydrogen Joint Undertaking
Amendment 727 #
Article 71 – paragraph 1 – introductory part
1. In addition to the objectives set out in Articles 4 and 5, the CleanRenewable Hydrogen Joint Undertaking shall also have the following general objectives:
Amendment 731 #
Article 71 – paragraph 1 – point a
(a) to contribute to the objectives set out in the 2030 Climate Target Plan51 , and the European Green Deal52 , by raising the EU's ambition on reducing greenhouse gas emissions to at least 55% below 1990 levels by 2030, and climate neutrality by 2050 at latest; _________________ 51 COM/2020/562 final. 52Communication from the Commission to the European Parliament, the European Council, the Council, the European Economic and Social Committee and the Committee of the Regions, COM/2019/640 final.
Amendment 737 #
Article 71 – paragraph 1 – point c
(c) to develop and strengthen the competitiveness of the Union cleanUnion's leadership in renewable hydrogen value chain, with a view to supporting, notably the SMEs involved, accelerating the market entry of innovative competitive clean solutions;
Amendment 738 #
Article 71 – paragraph 1 – point d
(d) to stimulate cleanrenewable hydrogen production, including the production of additional renewable energy, distribution, storage and end use applications.
Amendment 742 #
Article 71 – paragraph 2 – introductory part
2. The CleanRenewable Hydrogen Joint Undertaking shall also have the following specific objectives:
Amendment 746 #
Article 71 – paragraph 2 – point a
(a) improve through research and innovation the cost-effectivenessaffordability, reliability, quantity and quality of cleanrenewable hydrogen solutions, including production, distribution, storage and end uses developed in the Union such as more efficient and cheaper hydrogen electrolysers and cheaper transport and industrial applications;
Amendment 750 #
Article 71 – paragraph 2 – point c
(c) carry out demonstrations of cleanrenewable hydrogen solutions with the view to local, regional and Union-wide deployment, addressing renewable production, distribution, storage, and use for transport and energy-intensive industries as well as other applications;
Amendment 752 #
Article 71 – paragraph 2 – point d
(d) increase public and private awareness, acceptance, and uptake of clean of renewable hydrogen solutions, in particular through cooperation with other European partnerships under Horizon Europe.
Amendment 755 #
Article 72 – title
Additional tasks of the CleanRenewable Hydrogen Joint Undertaking
Amendment 756 #
Article 72 – paragraph 1 – introductory part
In addition to the tasks set out in Article 5, the CleanRenewable Hydrogen Joint Undertaking shall also carry out the following tasks:
Amendment 759 #
Article 72 – paragraph 1 – point a
(a) assess and monitor technological progress and technological, economic and, societal and ecological barriers to market entry;
Amendment 760 #
Article 72 – paragraph 1 – point b
Amendment 764 #
Article 72 – paragraph 1 – point c
(c) supporwhere appropriate, assist the Commission in its international initiatives on the hydrogen strategy, such as the International Partnership on the Hydrogen Economy (IPHE), Mission Innovation and the Clean Energy Ministerial Hydrogen Initiative while avoiding the relocation of environmental impacts, including greenhouse gas emissions.
Amendment 765 #
Article 73 – paragraph 1 – introductory part
The members of the CleanRenewable Hydrogen Joint Undertaking shall be:
Amendment 766 #
Article 73 – paragraph 1 – point b
(b) the Hydrogen Europe AISBL, a non-profit organisation established under Belgian Law (registration number: 890 025 478) with its permanent office in Brussels, Belgium (the ‘Industry Grouping’), upon notification of its decision to unconditionally accede to the CleanRenewable Hydrogen Joint Undertaking by means of a letter of commitment;
Amendment 767 #
Article 73 – paragraph 1 – point c
(c) the Hydrogen Europe Research AISBL, a non-profit organisation established under Belgian Law (registration number: 0897 679 372) with its permanent office in Brussels, Belgium (the ‘Research Grouping’), upon notification of its decision to unconditionally accede to the CleanRenewable Hydrogen Joint Undertaking by means of a letter of commitment.
Amendment 770 #
Article 75 – paragraph 1
1. The members of the CleanRenewable Hydrogen Joint Undertaking other than the Union shall make or arrange for their constituent or affiliated entities to make a total contribution of at least EUR 1 000 000 000, including up to EUR 30 193 000 for administrative costs over the period set out in Article 3.
Amendment 772 #
Article 75 – paragraph 2
2. The contribution referred to in paragraph 1 of this Article shall consist of contributions to the CleanRenewable Hydrogen Joint Undertaking in accordance with Article 11(1).
Amendment 776 #
Article 76 – paragraph 2
Amendment 777 #
Article 77 – paragraph 1 – introductory part
The bodies of the CleanRenewable Hydrogen Joint Undertaking shall be the following:
Amendment 786 #
Article 80 – paragraph 1 – point a
(a) foster synergies with relevant activities and programmes at Union, national, and regional level, in particular with those supporting the deployment of research and innovation solutions, infrastructure, education and regional development on the use of cleanrenewable hydrogen;
Amendment 789 #
Article 80 – paragraph 1 – point c
(c) encourage market uptake of sustainable technologies and solutions for achieving the European Green Deal’s objectives, in particular climate and energy targets.
Amendment 791 #
Article 81 – paragraph 1 – introductory part
In addition to the tasks set out in Article 18, the Executive Director of the CleanRenewable Hydrogen Joint Undertaking shall carry out the following tasks:
Amendment 795 #
Article 81 – paragraph 1 – point b
(b) support and contribute to other Union initiatives related to renewable hydrogen, subject to approval by the Governing Board;
Amendment 797 #
Article 81 – paragraph 1 – point c
(c) convene an annual European CleanRenewable Hydrogen partnership forum, which, where possible, shall be held jointly and in parallel with the European Hydrogen Forum of the Clean Hydrogen Alliance.
Amendment 799 #
Article 82 – paragraph 1
1. The provisions of Article 21 shall apply mutatis mutandis to the Stakeholders Group of the CleanRenewable Hydrogen Joint Undertaking.
Amendment 802 #
Article 82 – paragraph 2
2. The Stakeholders Group shall consist of representatives of sectors which generate, distribute, store, need or use cleanrenewable hydrogen across the Union, including the representatives of other relevant European partnerships, as well as representatives of the European Hydrogen Valleys Interregional Partnershipnewable electricity sector and civil society organisations.
Amendment 803 #
Article 82 – paragraph 3 – point a
(a) provide input on the strategic and the technological priorities to be addressed by the CleanRenewable Hydrogen Joint Undertaking as laid down in the Strategic Research and Innovation Agenda or any other equivalent document and associated detailed technological roadmaps, taking due account of the progress and needs in adjacent sectors such as transport and hard-to-decarbonised industry;
Amendment 806 #
Article 82 – paragraph 3 – point b
(b) provide suggestions to enable concrete synergies to take place between the CleanRenewable Hydrogen Joint Undertaking and the adjacent sectors or any sector with which synergies are deemed of added value following the energy system integration priorities;
Amendment 808 #
Article 82 – paragraph 3 – point c
Amendment 810 #
Article 83 – paragraph 1 – point b
(b) ensure a fast transition to more attractive, user-friendly, competitive, affordable, efficient and sustainable European rail system, integrated into the wider mobility system;
Amendment 811 #
Article 83 – paragraph 1 – point c
(c) support the development of a strong and globally competitive European rail industry.
Amendment 817 #
Article 83 – paragraph 2 – point f
(f) contribute to the development of a strong and globally competitive European rail industry.
Amendment 837 #
Article 97 – paragraph 1 – point a
(a) to reduce the socio-economic burden of infectious diseases, in particular poverty- related and neglected diseases, in sub- Saharan Africa promoting the development and uptake of new or improved health technologies; that are affordable, accessible and suitable for low resource settings.
Amendment 840 #
Article 97 – paragraph 2 – point b
(b) to strengthen research and innovation capacity and the national health research systems in sub-Saharan Africa for tackling infectious diseases and increase the proportion of projects with African leadership;
Amendment 842 #
Article 102 – paragraph 2 – point a
(a) activities of constituent entities of the EDCTP Association coordinated, co- programmed or aligned with similar activities from other constituent entities of the EDCTP Association and independently managed in accordance with national funding rules; The alignment of such activities needs to be demonstrated;
Amendment 845 #
Article 106 – paragraph 1 a (new)
1 a. The Scientific committee shall have a balanced representation of stakeholders from geographic, thematic and gender perspective, and in particular include Africa expertise.
Amendment 850 #
Article 107 a (new)
Article 107 a The Stakeholders Group shall have a balanced representation of stakeholders from a geographic, thematic and gender perspective, including in particular African expertise, and should foster membership and meaningful involvement of civil society, especially non- governmental organisations working with communities most affected bypoverty- related and neglected infectious diseases.
Amendment 853 #
Article 111 – paragraph 1
The Global Health EDCTP3 Joint Undertaking shall ensure a close collaboration with the European Medicine Agency and European Centre for Disease Prevention and Control. as well as with relevant African agencies and organisations, including the African Centres for Disease Control, African Union's Regional Communities, NEPAD- AUDA and the African Academy of Sciences;
Amendment 857 #
Article 112 – paragraph 1
Participants to indirect actions funded by the Global Health EDCTP3 Joint Undertaking shall ensure that the products and services developed based or partly based on the results of the indirect action are available and, accessible to the publicand affordable for vulnerable populations and to the public in general, in particular in low resource settings at fair and reasonable conditions. For that purpose, where relevant, the work programme shall specify additional exploitation obligations applicable to specific indirect actions.
Amendment 859 #
Article 113 – paragraph 1 – point b
(b) foster the development of safe, effective, people-centred affordable for patients and for health care systems and cost-effective innovations that respond to strategic unmet public health needs, by exhibiting, in at least five examples, the feasibility of integrating health care products or services, with demonstrated suitability for uptake by health care systems. The related projects should address the surveillance, prevention, early diagnosis, treatment and/or management of diseases affecting the Union population, including contribution to Europe’s Beating Cancer Planthe fight against cancer in synergy with the Europe’s Beating Cancer Plan, and by supporting the establishment of the European Cancer Institute and the European One Health Action Plan against Antimicrobial Resistance;
Amendment 862 #
Article 113 – paragraph 1 – point c
Amendment 866 #
Article 113 – paragraph 2 – point a
(a) contribute towards a better understanding of the determinants of health, such as behaviour-related, biological, socio-economic and environmental factors that influence the health status of a person and priority disease areas;
Amendment 871 #
Article 113 – paragraph 2 – point d
(d) exploit the full potential of digitalisation and data exchange in health care without jeopardizing data protection and privacy of the people;
Amendment 894 #
Article 122 – paragraph 2 – point d
(d) twosix representatives of the scientific community, appointed by the Governing Board following an open selection process in application of Article 19(4);
Amendment 897 #
Article 122 – paragraph 2 – point e
(e) up to six permanent panellists, appointed by the Governing Board following an open selection process in application of Article 19(4), ensuring in particular appropriate representation of stakeholders involved in health care, covering notably the public sector, patients and end-users in general;
Amendment 905 #
Article 122 – paragraph 5
5. The Innovation Panel shall be chaired by the Executive Director. In duly justified cases, the Executive Director may appoint a senior member of staff of the Innovative Health Initiative Joint Undertaking programme office to chair the Innovation Panel on his or her behalfpermanent representatives of the Innovation Panel shall elect its chair from among its members, in application of article 19(5).
Amendment 910 #
Article 122 – paragraph 8 – point 1 (new)
(1) 9. The permanent representatives of the Innovation Panel shall be appointed based on their competences and expertise, in order to make science- and health needs-based recommendations to the joint undertaking.
Amendment 911 #
Article 122 – paragraph 8 – point 2 (new)
Amendment 918 #
Article 123 – paragraph 1
1. For the purpose of this Regulation, an unmet public health need shall be defined as a need currently not addressed by the health care systems for affordability, availability or accessibility reasons, for example where there is no satisfactory method of diagnosis, prevention or treatment for a given health condition or if people access to health care is limited because of cost, distance to health facilities or waiting times in line with WHO priority medicines for Europe and the World, and other WHO reports. People-centred care refers to an approach to care that consciously adopts individuals’, carers’, families’ and communities’ perspectives and considers them as participants as well as beneficiaries of health care systems that are organised around their needs and preferences rather than individual diseases.
Amendment 924 #
Article 124 – paragraph 1 – point c
(c) ensure that components and systems technologies address Europe’s societal and environmental challenges, including energy and resource efficiency. The target is to align with the Union policy on energy efficiency and contribute towards the reduction of energy consumption by 32.5% in 2030.
Amendment 959 #
Article 142 – paragraph 1 – point b
(b) strengthen, through innovation, the competitiveness of manned and unmanned air transport in the Union, and ATM services’ markets to support economic growth in the Union;
Amendment 963 #
Article 143 – paragraph 1 – point b – point iii
(iii) ensuring the involvement of the civil and military stakeholders of the aviation sector, in particular: air navigation service providers, airspace users, professional staff associations, airports, manufacturing industry and the relevant scientific institutions and scientific community;
Amendment 967 #
Article 150 – paragraph 2 – point a
Amendment 979 #
Article 159 – paragraph 1 – point f
(f) facilitate digital innovation, by 2030, meeting European market needs and public policy requirements, including the most demanding requirements of vertical industries, as well as societal requirements in fields including securiafety, energy efficiency, and electromagnetic fields;
Amendment 984 #
Article 159 – paragraph 2 – point e
(e) strenghten the positioning of the Union’s industry, specially SME's in the global smart network and services value chain by creating a critical mass of public and private actors, in particular by increasing the contribution from software and Internet of Things actors, leveraging national initiatives and supporting the emergence of new actors;
Amendment 1005 #
Article 171 – paragraph 2 – introductory part
2. The joint undertakings should organise continuous monitoring of their management activities and periodic reviews of the outputs, results and impacts of their projects implemented in accordance with [Article 45] and [Annex III] of the Horizon Europe Regulation. That monitoring shall result in annual progress reports that are made public on the respective website of each partnership in timely manner, and shall include: